| 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|
| Gross margin | 70,4 k € | +2557.5% | 2,6 k € | +130.1% | -8,8 k € | |
| EBITDA | 20,2 k € | +664.3% | 2,6 k € | +128.8% | -9,2 k € | |
| Operating profit | 20,2 k € | +664.3% | 2,6 k € | +125.3% | -10,5 k € | |
| Profit/loss | 16,8 k € | +558.3% | 2,6 k € | +124.4% | -10,5 k € | |
| Equity | 70,9 k € | +31.1% | 54,1 k € | +5.0% | 51,5 k € | |
| Total assets | 118,9 k € | +56.0% | 76,2 k € | +4.5% | 72,9 k € | |
| Cash | 394,2 € | +182.9% | 139,3 € | -99.4% | 22,6 k € | |
| Debts | 48,0 k € | +116.8% | 22,1 k € | +3.3% | 21,4 k € | |
Public limited company · Gent · incorporated on 25/02/2022
Public limited company profitable and well capitalised. Cash position rising (+182.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
CARDON BIO is a Public limited company incorporated in 2022. Its main activity is: Retail sale of medical and orthopaedic goods in specialised stores. Its registered office is in Gent.